Our updated study, with longer follow-up, on effectiveness of the #influenzavaccine still fails to find the vaccine to be effective in protecting against #influenza this year. https://t.co/6SSXCto2VR
The #influenzavaccine varies in its effectiveness from season to season. This prospective study has been unable to find the vaccine to be effective thus far this respiratory season, in protecting against #influenza. https://t.co/46054LBiey
The commercial imperative to extract money from human bodies is playing havoc. Nowhere is this more apparent than in the field of vaccines, and their place in determining the length of our lives.
~@bell00david
Vaccines and the Length of Our Lives
https://t.co/1brsepqKbn
We need to return to reality on pandrmics, rather than flawed models.
The world has changed. The pandemic industry seems stuck in the Middle Ages.
https://t.co/2xz04N6kwM
Excited for the official CCF Infectious Diseases Fellowship account ! Follow us for updates on ID education, research, and insights from our fellows.
#InfectiousDiseases#MedicalEducation#IDFellows
‘Hybrid immunity’ is a construct of Pharma to sell vaccines that:
1. Don’t stop infection, or
2. The company wants to inject into already-immune people.
But perhaps scientific journals should separate advertising from science.
Immunity is immunity.
https://t.co/nELrBaHPgM
@bell00david Fully agree. My position exactly. I have reviewed every paper that has been sent to me to “prove” the value of “hybrid immunity”, and each one of them is built on faulty premises and the findings misinterpreted to further the narrative that “hybrid immunity” is somehow better.
@DrDeepMD@ClevelandClinic It is wrong to vilify all vaccines. Vaccines have saved many many lives. However benefits of particular vaccines should not be overstated, and we should be willing to consider the possibility that potential harms from weakly effective vaccines may overshadow their benefits.
@thatsnotmine125@DrAseemMalhotra This study was not about vaccine efficacy or safety. It was about the usefulness of classifying people into “up-to-date” or “not up-to-date” on COVID-19 vaccination.
As defined by current CDC criteria, those who have not received a single dose of the bivalent vaccine are considered to not be up-to-date with COVID-19 vaccination. This study calls into question the validity of this classification. https://t.co/EU7XBFdzez
Important questions about duration of immunity after COVID-19 infection/vaccination, and timing and number of vaccine doses needed for those previously infected, are examined in this study.
https://t.co/oazmfFDiaN
@martin_ssanchez@CDCgov It’s important to consider absolute benefit too, not just relative benefit. May be a benefit to vaccination in this age group but it does not seem as great as is generally portrayed and is at a level where risks have to be considered